New publication!

Our latest study in Int. J. Mol. Sci. highlights the critical role of bone marrow endothelial cells (ECs) in driving multiple myeloma (MM) progression and resistance. Using single-cell RNA sequencing and novel isolation protocols, we showed that MM-derived ECs promote tumor growth and angiogenesis, offering new therapeutic targets to disrupt MM progression.
Read the full article here.